Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease

Journal of Comparative Neurology

Volumn 501, Issue 1, 2007, Pages 168-183

  Hu, Huaiyu ^a   Yang, Yuan ^a,b   Eade, Amber ^a   Xiong, Yufang ^a   Qi, Yue ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b Tongji Hospital   (China)

Author keywords

Basement membrane; Cerebral cortical development; Glia limitans; Neuronal migration; OmniBank; POMGnT1

Indexed keywords

N ACETYLGLUCOSAMINYLTRANSFERASE; PROTEIN POMGNT1; UNCLASSIFIED DRUG; AMINO ACID; BROXURIDINE; DIAGNOSTIC AGENT; DOLAISOLEUCINE; GREEN FLUORESCENT PROTEIN; PHOTOPROTEIN; PROTEIN O MANNOSE BETA 1,2 N ACETYLGLUCOSAMINYLTRANSFERASE; PROTEIN O-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE; YELLOW FLUORESCENT PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN MALFORMATION; BRAIN REGION; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FETUS; GLIA; KNOCKOUT MOUSE; MOUSE; MUSCLE EYE BRAIN DISEASE; MUSCULAR DYSTROPHY; NERVE CELL MEMBRANE; NEUROPATHOLOGY; NEWBORN; NONHUMAN; PIA MATER; PRIORITY JOURNAL; ANIMAL; CELL MOTION; CELL PROLIFERATION; CONGENITAL MALFORMATION; DISEASE MODEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; METHODOLOGY; NERVE CELL; NERVOUS SYSTEM MALFORMATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; BASEMENT MEMBRANE; BROMODEOXYURIDINE; CELL MOVEMENT; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; EMBRYONIC DEVELOPMENT; GREEN FLUORESCENT PROTEINS; GROWTH; LUMINESCENT PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCULAR DYSTROPHIES; MUTATION; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEUROGLIA; NEURONS; PIA MATER; AMINO ACIDS; ANIMALS, NEWBORN; CELL PROLIFERATION; EMBRYO; MICROSCOPY, ELECTRON, TRANSMISSION; NERVOUS SYSTEM MALFORMATIONS;

EID: 33846522301     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21238     Document Type: Article

References (55)

1. Bai J, Ramos RL, Ackman JB, Thomas AM, Lee RV, LoTurco JJ. 2003. RNAi reveals doublecortin is required for radial migration in rat neocortex. Nat Neurosci 6:1277-1283.
2. Beggs HE, Schahin-Reed D, Zang K, Goebbels S, Nave KA, Gorski J, Jones KR, Sretavan D, Reichardt LF. 2003. FAK deficiency in cells contributing to the basal lamina results in cortical abnormalities resembling congenital muscular dystrophies. Neuron 40:501-514.
3. Beltran-Valero de BD, Currier S, Steinbrecher A, Celli J, van BE, van der ZB, Kayserili H, Merlini L, Chitayat D, Dobyns WB, Cormand B, Lehesjoki AE, Cruces J, Voit T, Walsh CA, van BH, Brunner HG. 2002. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 71:1033-1043.
4. Beltran-Valero de BD, Voit T, Longman C, Steinbrecher A, Straub V, Yuva Y, Herrmann R, Sperner J, Korenke C, Diesen C, Dobyns WB, Brunner HG, van BH, Brockington M, Muntoni F. 2004. Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. J Med Genet 41:e61.
5. Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Ponting CP, Estournet B, Romero NB, Mercuri E, Voit T, Sewry CA, Guicheney P, Muntoni F. 2001a. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 69:1198-1209.
6. Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, Benson MA, Herrmann R, Anderson LV, Bashir R, Burgunder JM, Fallet S, Romero N, Fardeau M, Straub V, Storey G, Pollitt C, Richard I, Sewry CA, Bushby K, Voit T, Blake DJ, Muntoni F. 2001b. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 21 as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 10:2851-2859.
7. Caviness VS Jr, Sidman RL. 1973. Time of origin or corresponding cell classes in the cerebral cortex of normal and reeler mutant mice: an autoradiographic analysis. J Comp Neurol 148:141-151.
8. Chanas-Sacre G, Thiry M, Pirard S, Rogister B, Moonen G, Mbebi C, Verdiere-Sahuque M, Leprince P. 2000. A 295-kDA intermediate filament-associated protein in radial glia and developing muscle cells in vivo and in vitro. Dev Dyn 219:514-525.
9. Chiba A, Matsumura K, Yamada H, Inazu T, Shimizu T, Kusunoki S, Kanazawa I, Kobata A, Endo T. 1997. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J Biol Chem 272:2156-2162.
10. Chiyonobu T, Sasaki J, Nagai Y, Takeda S, Funakoshi H, Nakamura T, Sugimoto T, Toda T. 2005. Effects of fukutin deficiency in the developing mouse brain. Neuromuscul Disord 15:416-426.
11. Demyanenko GP, Schachner M, Anton E, Schmid R, Feng G, Sanes J, Maness PF. 2004. Close homolog of L1 modulates area-specific neuronal positioning and dendrite orientation in the cerebral cortex. Neuron 44:423-437.
12. Dulabon L, Olson EC, Taglienti MG, Eisenhuth S, McGrath B, Walsh CA, Kreidberg JA, Anton ES. 2000. Reelin binds alpha3beta1 integrin and inhibits neuronal migration. Neuron 27:33-44.
13. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR. 2000. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28:41-51.
14. Fox JW, Walsh CA. 1999. Periventricular heterotopia and the genetics of neuronal migration in the cerebral cortex. Am J Hum Genet 65:19-24.
15. Frotscher M, Haas CA, Forster E. 2003. Reelin controls granule cell migration in the dentate gyrus by acting on the radial glial scaffold. Cereb Cortex 13:634-640.
16. Gee SH, Montanaro F, Lindenbaum MH, Carbonetto S. 1994. Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77:675-686.
17. Gleeson JG, Allen KM, Fox JW, Lamperti ED, Berkovic S, Scheffer I, Cooper EC, Dobyns WB, Minnerath SR, Ross ME, Walsh CA. 1998. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 92:63-72.
18. Graus-Porta D, Blaess S, Senften M, Littlewood-Evans A, Damsky C, Huang Z, Orban P, Klein R, Schittny JC, Muller U. 2001. Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron 31:367-379.
19. Halfter W, Dong S, Yip YP, Willem M, Mayer U. 2002. A critical fonction of the pial basement membrane in cortical histogenesis. J Neurosci 22:6029-6040.
20. Haltia M, Leivo I, Somer H, Pihko H, Paetau A, Kivela T, Tarkkanen A, Tome F, Engvall E, Santavuori P. 1997. Muscle-eye-brain disease: a neuropathological study. Ann Neurol 41:173-180.
21. Hartfuss E, Galli R, Heins N, Gotz M. 2001. Characterization of CNS precursor subtypes and radial glia. Dev Biol 229:15-30.
22. Hartfuss E, Forster E, Bock HH, Hack MA, Leprince P, Luque JM, Herz J, Frotscher M, Gotz M. 2003. Reelin signaling directly affects radial glia morphology and biochemical maturation. Development 130:4597-4609.
23. Hatten ME. 2002. New directions in neuronal migration. Science 297:1660-1663.
24. Henry MD, Campbell KP. 1999. Dystroglycan inside and out. Curr Opin Cell Biol 11:602-607.
25. Hu H. 2000. Polysialic acid regulates chain formation by migrating olfactory interneuron precursors. J Neurosci Res 61:480-492.
26. Jimenez-Mallebrera C, Brown SC, Sewry CA, Muntoni F. 2005. Congenital muscular dystrophy: molecular and cellular aspects. Cell Mol Life Sci 62:809-823.
27. Kano H, Kobayashi K, Herrmann R, Tachikawa M, Manya H, Nishino I, Nonaka I, Straub V, Talim B, Voit T, Topaloglu H, Endo T, Yoshikawa H, Toda T. 2002. Deficiency of alpha-dystroglycan in muscle-eye-brain disease. Biochem Biophys Res Commun 291:1283-1286.
28. Kim DS, Hayashi YK, Matsumoto H, Ogawa M, Noguchi S, Murakami N, Sakuta R, Mochizuki M, Michele DE, Campbell KP, Nonaka I, Nishino I. 2004. POMT1 mutation results in defective glycosylation and loss of laminin-binding activity in alpha-DG. Neurology 62:1009-1011.
29. Kobayashi K, Nakahori Y, Miyake M, Matsumura K, Kondo-Iida E, Nomura Y, Segawa M, Yoshioka M, Saito K, Osawa M, Hamano K, Sakakihara Y, Nonaka I, Nakagome Y, Kanazawa I, Nakamura Y, Tokunaga K, Toda T. 1998. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394:388-392.
30. Liu J, Zhang L, Wang D, Shen H, Jiang M, Mei P, Hayden PS, Sedor JR, Hu H. 2003. Congenital diaphragmatic hernia, kidney agenesis and cardiac defects associated with Slit3-denciency in mice. Mech Dev 120:1059-1070.
31. Liu J, Ball SL, Yang Y, Mei P, Zhang L, Shi H, Kaminski HJ, Lemmon VP, Hu H. 2006. A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose beta1,2-N-acetylglucosaminyltransferase (POMGnT1). Mech Dev 123:228-240.
32. Longman C, Brockington M, Torelli S, Jimenez-Mallebrera C, Kennedy C, Khalil N, Feng L, Saran RK, Voit T, Merlini L, Sewry CA, Brown SC, Muntoni F. 2003. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet 12:2853-2861.
33. Manya H, Sakai K, Kobayashi K, Taniguchi K, Kawakita M, Toda T, Endo T. 2003. Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease. Biochem Biophys Res Commun 306:93-97.
34. Marin O, Rubenstein JL. 2003. Cell migration in the forebrain. Annu Rev Neurosci 26:441-483.
35. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP. 2002. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418:417-422.
36. Miller MW. 1985. Cogeneration of retrogradely labeled corticocortical projection and GABA-immunoreactive local circuit neurons in cerebral cortex. Brain Res 355:187-192.
37. Miller MW, Nowakowski RS. 1988. Use of bromodeoxyuridine- immunohistochemistry to examine the proliferation, migration and time of origin of cells in the central nervous system. Brain Res 457:44-52.
38. Misson JP, Edwards MA, Yamamoto M, Caviness VS Jr. 1988. Identification of radial glial cells within the developing murine central nervous system: studies based upon a new immunohistochemical marker. Brain Res Dev Brain Res 44:95-108.
39. Montanaro F, Lindenbaum M, Carbonetto S. 1999. Alpha-dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability. J Cell Biol 145:1325-1340.
40. Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP. 2002. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418:422-425.
41. Niewmierzycka A, Mills J, St.-Arnaud R, Dedhar S, Reichardt LF. 2005. Integrin-linked kinase deletion from mouse cortex results in cortical lamination defects resembling cobblestone lissencephaly. J Neurosci 25:7022-7031.
42. Oliva AA Jr, Jiang M, Lam T, Smith KL, Swann JW. 2000. Novel hippocampal interneuronal subtypes identified using transgenic mice that express green fluorescent protein in GABAergic interneurons. J Neurosci 20:3354-3368.
43. Rakic P. 1990. Principles of neural cell migration. Experientia 46:882-891.
44. Rice DS, Curran T. 2001. Role of the reelin signaling pathway in central nervous system development. Annu Rev Neurosci 24:1005-1039.
45. Ross ME, Walsh CA. 2001. Human brain malformations and their lessons for neuronal migration. Annu Rev Neurosci 24:1041-1070.
46. Smalheiser NR, Haslam SM, Sutton-Smith M, Morris HR, Dell A. 1998. Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain. J Biol Chem 273:23698-23703.
47. Soriano E, Del Rio JA. 2005. The cells of Cajal-Retzius: still a mystery one century after. Neuron 46:389-394.
48. Tissir F, Goffinet AM. 2003. Reelin and brain development. Nat Rev Neurosci 4:496-505.
49. Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, Hammer RE, Richardson JA, Herz J. 1999. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97:689-701.
50. van der Knaap MS, Smit LM, Barth PG, Catsman-Berrevoets CE, Brouwer OF, Begeer JH, de Coo IF, Valk J. 1997. Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann Neurol 42:50-59.
51. van Reeuwijk J, Janssen M, van den Elzen C, Beltran-Valero de Bernabe D, Sabatelli P, Merlini L, Boon M, Scheffer H, Brockington M, Muntoni F, Huynen M, Verrips A, Walsh C, Barth P, Brunner H, van Bokhoven H. 2005. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker Warburg syndrome. J Med Genet 42:907-912.
52. Weiss KH, Johanssen C, Tielsch A, Herz J, Deller T, Frotscher M, Forster E. 2003. Malformation of the radial glial scaffold in the dentate gyrus of reeler mice, scrambler mice, and ApoER2/VLDLR-defieient mice. J Comp Neurol 460:56-65.
53. Yoshida A, Kobayashi K, Manya H, Taniguchi K, Kano H, Mizuno M, Inazu T, Mitsuhashi H, Takahashi S, Takeuchi M, Herrmann R, Straub V, Talim B, Voit T, Topaloglu H, Toda T, Endo T. 2001. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 1:717-724.
54. Zhang W, Betel D, Schachter H. 2002. Cloning and expression of a novel UDP-GlcNAc:alpha-D-mannoside beta1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:alpha-3-D-mannoside beta1,2-N- acetylglucosaminyltransferase I. Biochem J 361:153-162.
55. Zhao S, Chai X, Forster E, Frotscher M. 2004. Reelin is a positional signal for the lamination of dentate granule cells. Development 131:5117-5125.